Abbott Laboratories (LON: 0Q15)
London flag London · Delayed Price · Currency is GBP · Price in USD
114.51
+1.23 (1.09%)
At close: Dec 20, 2024

Abbott Laboratories Company Description

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.

It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories.

In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders.

Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories
Country United States
Founded 1888
Industry Electromedical and Electrotherapeutic Apparatus
Employees 114,000
CEO Robert Ford

Contact Details

Address:
100 Abbott Park Road
North Chicago, Illinois 60064-6400
United States
Phone 224 667 6100
Website abbott.com

Stock Details

Ticker Symbol 0Q15
Exchange London Stock Exchange
Fiscal Year January - December
Reporting Currency USD
ISIN Number US0028241000
SIC Code 3845

Key Executives

Name Position
Robert Ford Chief Executive Officer
Philip Boudreau Chief Financial Officer
Michael Comilla Head of Investor Relations